16-75542641-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4

The NM_001077418.3(TMEM231):​c.625G>A​(p.Asp209Asn) variant causes a missense change. The variant allele was found at a frequency of 0.0000428 in 1,613,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000043 ( 0 hom. )

Consequence

TMEM231
NM_001077418.3 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:6U:1

Conservation

PhyloP100: 3.81
Variant links:
Genes affected
TMEM231 (HGNC:37234): (transmembrane protein 231) This gene encodes a transmembrane protein, which is a component of the B9 complex involved in the formation of the diffusion barrier between the cilia and plasma membrane. Mutations in this gene cause Joubert syndrome (JBTS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-75542641-C-T is Pathogenic according to our data. Variant chr16-75542641-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 39822.We mark this variant Likely_pathogenic, oryginal submissions are: {Pathogenic=3, Likely_pathogenic=1, Uncertain_significance=1}. Variant chr16-75542641-C-T is described in Lovd as [Likely_pathogenic]. Variant chr16-75542641-C-T is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (MetaRNN=0.34586817). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TMEM231NM_001077418.3 linkuse as main transcriptc.625G>A p.Asp209Asn missense_variant 5/7 ENST00000258173.11
TMEM231NM_001077416.2 linkuse as main transcriptc.784G>A p.Asp262Asn missense_variant 4/6
TMEM231NR_074083.2 linkuse as main transcriptn.791G>A non_coding_transcript_exon_variant 5/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TMEM231ENST00000258173.11 linkuse as main transcriptc.625G>A p.Asp209Asn missense_variant 5/71 NM_001077418.3 P1Q9H6L2-1

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
152074
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000682
AC:
17
AN:
249258
Hom.:
0
AF XY:
0.0000592
AC XY:
8
AN XY:
135226
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000556
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000496
GnomAD4 exome
AF:
0.0000431
AC:
63
AN:
1461640
Hom.:
0
Cov.:
30
AF XY:
0.0000468
AC XY:
34
AN XY:
727102
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000540
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
152074
Hom.:
0
Cov.:
31
AF XY:
0.0000538
AC XY:
4
AN XY:
74290
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000485
Hom.:
0
Bravo
AF:
0.0000378
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000120
AC:
1
ExAC
AF:
0.0000827
AC:
10
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000356

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:6Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 20, 2017- -
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxFeb 08, 2024Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23012439, 27449316, 26477546) -
Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 20, 2023This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 262 of the TMEM231 protein (p.Asp262Asn). This variant is present in population databases (rs200799769, gnomAD 0.01%). This missense change has been observed in individual(s) with Joubert syndrome (PMID: 23012439, 27449316). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as Asp209Asn. ClinVar contains an entry for this variant (Variation ID: 39822). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic. -
Joubert syndrome and related disorders Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 01, 2023Variant summary: TMEM231 c.784G>A (p.Asp262Asn) results in a conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 6.8e-05 in 249258 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in TMEM231 causing Joubert Syndrome And Related Disorders (6.8e-05 vs 0.0004), allowing no conclusion about variant significance. c.784G>A has been reported in the literature in multiple individuals affected with Joubert Syndrome And Related Disorders (e.g., Srour_2012, Maglic_2016). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, and all laboratories classified the variant as pathogenic (n = 2) or likely pathogenic (n = 1). Based on the evidence outlined above, the variant was classified as pathogenic. -
TMEM231-related disorder Pathogenic:1
Pathogenic, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMar 19, 2024The TMEM231 c.784G>A variant is predicted to result in the amino acid substitution p.Asp262Asn. This variant can also be referred to as (NM_001077418.1:c.625G>A (p.Asp209Asn). This variant, along with a protein truncating variant has been previously identified in three individuals with Joubert syndrome (JS) from two different families (Srour et al. 2012. PubMed ID: 23012439). Also, this variant along with an exonic deletion has been reported in three affected individuals with JS (Maglic et al. 2016. PubMed ID: 27449316). This variant is reported in 0.012% of alleles in individuals of European (Non-Finnish) descent in gnomAD. This variant is interpreted as pathogenic. -
Joubert syndrome 20 Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 01, 2012- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 16, 2022The c.712G>A (p.D238N) alteration is located in exon 4 (coding exon 4) of the TMEM231 gene. This alteration results from a G to A substitution at nucleotide position 712, causing the aspartic acid (D) at amino acid position 238 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
21
DANN
Uncertain
0.97
DEOGEN2
Benign
0.13
T;.;T
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.51
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.81
T;T;T
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.35
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.7
L;.;.
MutationTaster
Benign
0.98
D;D;D
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-1.6
N;.;N
REVEL
Benign
0.17
Sift
Benign
0.20
T;.;T
Sift4G
Uncertain
0.039
D;D;T
Polyphen
0.079
B;.;.
Vest4
0.34
MVP
0.28
MPC
0.012
ClinPred
0.32
T
GERP RS
2.3
Varity_R
0.056
gMVP
0.46

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200799769; hg19: chr16-75576539; COSMIC: COSV99259910; COSMIC: COSV99259910; API